COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1204: Articles 12031-12040  | Next

Examining the Association between the COVID-19 Pandemic and Self-Harm Death Counts in Four Canadian Provinces
Isnar, S., Oremus, M.
10.1101/2021.10.13.21264961 — Posted: 2021-10-14
COVID-19 and Mental Health: Predicted Mental Health Status is Associated with Clinical Symptoms and Pandemic-Related Psychological and Behavioral Responses
Chung, J. Y., Gibbons, A., Atlas, L., Ballard, E., Ernst, M., Japee, S., Farmer, C., Shaw, J., Pereira, F.
10.1101/2021.10.12.21264902 — Posted: 2021-10-14
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant(B.1.617.2) of SARS-CoV-2
Pattni, K., Hungerford, D., Adams, S., Buchan, I., Cheyne, C. P., Garcia-Finana, M., Hall, I., Hughes, D. M., Overton, C., Zhang, X., Sharkey, K. J.
10.1101/2021.10.12.21264840 — Posted: 2021-10-14
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department
Beck, E. J., Hsieh, Y.-H., Fernandez, R. E., Dashler, G., Egbert, E. R., Truelove, S. A., Garliss, C., Wang, R., Bloch, E. M., Shrestha, R., Blankson, J. N., Cox, A. L., Manabe, Y. C., Kickler, T., Rothman, R. E., Redd, A. D., Tobian, A. A., Quinn, T. C., Laeyendecker, O.
10.1101/2021.10.13.21264968 — Posted: 2021-10-14
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominanceof Delta variant (B.1.617.2), August-September 2021, the Netherlands
de Gier, B., Andeweg, S., Backer, J. A., Hahne, S. J. M., van den Hof, S., de Melker, H. E., Knol, M. J.
10.1101/2021.10.14.21264959 — Posted: 2021-10-14 Discussion: Onsite
Modeling and analysis of COVID-19 infected persons during repeated waves in Japan
Hashiguchi, K.
10.1101/2021.10.11.21264869 — Posted: 2021-10-14
SARS-CoV-2 vaccine antibody response and breakthrough infections in patients receiving dialysis
Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Cadden, L., Hunsader, P., Morgan, C., Kerschmann, R., Beyer, P., Dittrich, M., Block, G. A., Chertow, G. M., Parsonnet, J.
10.1101/2021.10.12.21264860 — Posted: 2021-10-14
The impact of heating, ventilation, and air conditioning design features on the transmission of viruses, including the 2019 novel coronavirus: a systematic review of ultraviolet radiation
Thornton, G. M., Fleck, B. A., Fleck, N., Kroeker, E., Dandnayak, D., Zhong, L., Hartling, L.
10.1101/2021.10.12.21264904 — Posted: 2021-10-14
Genome Recombination between Delta and Alpha Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Sekizuka, T., Itokawa, K., Saito, M., Shimatani, M., Matsuyama, S., Hasegawa, H., Saito, T., Kuroda, M., COVID-19 Genomic Surveillance Network in Japan (COG-JP)
10.1101/2021.10.11.21264606 — Posted: 2021-10-14
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients.
Khoo, N. K. H., Lim, J. M. E., Gill, U. S., de Alwis, R., Tan, N., Toh, J. Z. N., Abbott, J. E., Usai, C., Ooi, E. E., Low, J. G. H., Le Bert, N., Kennedy, P. T., Bertoletti, A.
10.1101/2021.10.14.21264981 — Posted: 2021-10-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).